MNOV

MEDICINOVA INC MNOV

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,841 of 2,925

Why it scores 13Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$458.4K

Quarter to Jun 30

Net income

$-2.31M

Quarter to Jun 30

Free cash flow

$-1.92M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$6.84M total
Essex Woodlands Management, Inc.
$1.46M0.0%
BlackRock, Inc.
$992.8K+6.5%
CITIGROUP INC
$839.1K0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$803.9K-0.3%
GEODE CAPITAL MANAGEMENT, LLC
$712.1K-0.8%
VANGUARD FIDUCIARY TRUST CO
$373.0K+0.7%
UBS Group AG
$293.3K0.0%
RENAISSANCE TECHNOLOGIES LLC
$271.1K+8.2%
STATE STREET CORP
$255.7K0.0%
NORTHERN TRUST CORP
$189.6K+7.9%
Bank of New York Mellon Corp
$103.3K0.0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$94.4K0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$74.0K0.0%
SBI Securities Co., Ltd.
$68.0K+14.7%
DIMENSIONAL FUND ADVISORS LP
$66.7K0.0%
BARCLAYS PLC
$56.5K-73.7%
Schonfeld Strategic Advisors LLC
$47.7K-0.6%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$35.3K-39.1%
JANE STREET GROUP, LLC
$20.9K-81.8%
Vanguard Global Advisers, LLC
$20.6K0.0%
TWO SIGMA INVESTMENTS, LP
$17.9K-54.6%
BANK OF AMERICA CORP /DE/
$17.4K-61.7%
Focus Partners Advisor Solutions, LLC
$13.2KNew
HANTZ FINANCIAL SERVICES, INC.
$6.0K0.0%
MORGAN STANLEY
$2.6K0.0%
See all 29 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/MNOV

Earnings Per Share

13fpro.ai/company/MNOV

Loading ratio trend…

MNOV key financials by period

Reported revenue, net income and operating margin by fiscal year, from MEDICINOVA INC's annual filings on SEC EDGAR.

MEDICINOVA INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$409.7K$-12.0M—
FY 2023$1.0M$-8.6M—
FY 2021$4.0M$-10.1M—
FY 2012$802.6K$-11.0M—
Source: MNOV filings on SEC EDGAR →

MNOV insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About MEDICINOVA INC (MNOV): stock profile, AI score and financials

MEDICINOVA INC (MNOV) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MNOV at 13.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,841 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), MEDICINOVA INC reports quarterly revenue of $458.4K, net income of $-2.3M, free cash flow of $-1.9M. Top institutional holders of MNOV by reported 13-F value include Essex Woodlands Management, BlackRock, CITIGROUP, based on the most recent SEC filings. MNOV trades on the Nasdaq exchange and files with the SEC under CIK 1226616. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MNOV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MEDICINOVA INC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1226616 →